Intracerebral Hemorrhage. Nontraumatic intracerebral hemorrhage in hemisphere, unspecified
Conditions
Interventions
Intervention 1: Intervention group:Tab Atorvastatin 40 mg per day will be administered for 45 days. In addition, routine medical treatment including antihypertensive drugs will be given to the patien
Sponsors
Shahid Beheshti University of Medical Sciences
Eligibility
Sex/Gender
All
Age
No minimum to 80 Years
Inclusion criteria
Inclusion criteria: Age 40 mg/dL.
Exclusion criteria
Exclusion criteria: Pregnancy. Coma at the time of admission. History of neurodegenerative disorders such as Alzheimer's disease, Multiple sclerosis, Parkinson's disease, previous stroke, and psychological problems. History of brain tumors. Intracerebral hemorrhage due to vascular malformation or coagulation disorders. Intracerebral hemorrhage which requires surgical evacuation.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Serum level of Matrix metallopeptidase 9. Timepoint: At the time of admission (before intervention) and after 14 and 45 days of Atorvastatin consumption. Method of measurement: Blood Sample.;Serum level of Vascular endothelial growth factor. Timepoint: At the time of admission (before intervention) and after 14 and 45 days of Atorvastatin consumption. Method of measurement: Blood Sample. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactEhsan Karimialavijeh
Tehran University of Medical Sciences
Outcome results
None listed